USPTO Examiner BOUCHELLE LAURA A - Art Unit 3783

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
19243315COMPOSITIONS, DEVICES, AND METHODS FOR INTRANASAL DELIVERY OF DRY POWDER EPINEPHRINEJune 2025October 2025Allow300NoNo
19045847INTRAVENOUS CATHETER LOCKFebruary 2025July 2025Allow510YesNo
19028654DRUG DELIVERY DEVICE WITH FEEDBACK MECHANISMJanuary 2025April 2025Allow310NoNo
18981958All-In-One Delivery Sheath/Catheter - NOORCATHDecember 2024May 2025Allow510YesNo
18862350FEMORAL ARTERY CANNULA FOR PROVIDING LOWER LIMB BLOOD PERFUSIONNovember 2024February 2025Allow400NoNo
18842993Test Fish Holding Device and Test Fish Treatment MethodAugust 2024May 2025Allow801NoNo
18819429Medicament Delivery DeviceAugust 2024April 2025Allow720NoNo
18819371Medicament Delivery DeviceAugust 2024August 2025Allow1120YesNo
18778749TOTAL JOINT REPLACEMENT INFECTION CONTROL DEVICES AND METHODSJuly 2024November 2024Allow400NoNo
18668929INFUSION PUMP SYSTEMS WITH DISPOSABLE CARTRIDGE HAVING PRESSURE VENTING AND PRESSURE FEEDBACKMay 2024May 2025Allow1210NoNo
18655121Systems and Methods for Monitoring Operations of an Infusion Delivery Device Using a Pressure SensorMay 2024July 2024Allow200NoNo
18646783LIQUID MEDICINE INJECTION DEVICEApril 2024July 2025Allow1410NoNo
18640710MEDICAMENT DELIVERY DEVICEApril 2024August 2024Allow310NoNo
18630157PATCH PUMP CARTRIDGE ATTACHMENTApril 2024March 2025Allow1110NoNo
18626216INFUSION PUMP FLOW RATE CONTROLApril 2024August 2025Allow1610NoNo
18620097COLLAR HOLD DETENT MECHANISM AND LOCK FOR INJECTION DEVICESMarch 2024September 2024Allow510NoNo
18619996HOLD DETENT MECHANISM FOR INJECTION DEVICESMarch 2024August 2024Allow510NoNo
18602886RAPID FLUID DELIVERY SYSTEMMarch 2024June 2025Abandon1510NoNo
18594556MEDICAMENT DELIVERY DEVICEMarch 2024August 2024Allow510YesNo
18436151PATIENT INTERFACEFebruary 2024April 2024Allow200NoNo
18406991FLUSHING APPARATUS FOR USE WITH AN IV INFUSION SET AND AN IV INFUSION SET HAVING AN AUTOMATIC FLUSHING FUNCTIONJanuary 2024September 2024Allow921NoNo
18407295INFUSION PUMP SYSTEMS AND METHODSJanuary 2024January 2025Allow1210NoNo
18401097SYSTEMS AND METHODS FOR DELIVERING MICRODOSES OF MEDICATIONDecember 2023April 2025Allow1610NoNo
18397882INTEGRATED LIQUID FLOW CLOSED LOOP SENSING AND CONTROLDecember 2023November 2025Allow2310NoNo
18541017DEVICES FOR STEERING CATHETERSDecember 2023September 2025Allow2120YesNo
18521817METHODS AND DEVICES FOR CONTROLLING A SHAPEABLE MEDICAL DEVICENovember 2023January 2026Allow2510NoNo
18389084FLUID HANDLING ASSEMBLY AND RELATED TUBE SET AND METHOD FOR USE IN SURGICAL PROCEDURESNovember 2023February 2026Allow2710NoNo
18506965SYSTEMS AND METHODS FOR DELIVERING MICRODOSES OF MEDICATIONNovember 2023December 2025Allow2510NoNo
18498210Infusion Catheter and Method of UseOctober 2023August 2025Allow2120YesNo
18494419CUSHION/FRAME SUB-ASSEMBLY CONNECTABLE TO OUTER FRAMEOctober 2023April 2024Allow620NoNo
18378852PORT LOCATOR FOR AN IMPLANTOctober 2023March 2026Allow2900NoNo
18484439METHODS, SYSTEMS, AND DEVICES FOR THE TREATMENT OF STENOSISOctober 2023January 2026Allow2720NoNo
18285476MEDICAL PENETRATION DEVICE AND SYSTEMOctober 2023March 2025Allow1720YesNo
18478899REMOVABLE WEARABLE DEVICE AND RELATED ATTACHMENT METHODSSeptember 2023March 2025Allow1821NoNo
18278538INTRACANALICULAR DEPOT INSERTER DEVICEAugust 2023January 2024Allow500NoNo
18449421SYSTEMS AND METHODS FOR PROVIDING A STEERABLE SHEATH WITH IMPROVED TORQUE TRANSFER DURING DEFLECTIONAugust 2023May 2024Allow900NoNo
18447903WEARABLE DRUG DELIVERY DEVICEAugust 2023May 2025Allow2121NoNo
18275878SYSTEMS AND METHODS FOR PRIMING A FLUID LINEAugust 2023September 2024Allow1420NoNo
18229970Plungerless Aspiration And/Or Injection Device And Method Using The SameAugust 2023February 2024Allow710YesNo
18359301DEVICES, SYSTEMS AND METHODS FOR DETACHMENT OF RELEASABLE DEVICESJuly 2023December 2023Allow400NoNo
18333150Another Insert Piece For A Blood Tubing Set To Promote Mixing An Infusion Solution With A Further FluidJune 2023October 2024Allow1610NoNo
18206436ADVANCED DIALYSIS CATHETER WITH PRESSURE SENSORJune 2023June 2025Abandon2410NoNo
18144480DECONSTRUCTABLE ENDOLUMINAL DEVICES AND RELATED SYSTEMS AND METHODSMay 2023February 2025Allow2121NoNo
18312527METHODS AND SYSTEMS FOR DELIVERING GAS TO A PATIENTMay 2023February 2025Allow2210NoNo
18134984PINCH CLAMPApril 2023September 2024Allow1710NoNo
18030845DELIVERY DEVICE WITH CAM DRIVEN PERISTALTIC PUMPApril 2023March 2026Allow3510NoNo
18030271LIQUID MEDICINE INJECTION DEVICEApril 2023January 2024Allow1010NoNo
18128559THERAPEUTIC AGENTS FOR DELIVERY USING A CATHETER AND PRESSURE SOURCEMarch 2023January 2025Allow2210NoNo
18127050Priming Valve to Induce Appropriate Pressure and Flow Profile and Improve Sensor ReadinessMarch 2023January 2025Allow2210NoNo
18189847DEVICES AND METHODS FOR INCREASING BLOOD PERFUSION TO A DISTAL EXTREMITYMarch 2023April 2024Allow1311NoNo
18124025CUSHION/FRAME ASSEMBLY FOR A PATIENT INTERFACEMarch 2023October 2023Allow710NoNo
18245948CATHETER DEVICE COMPRISING A SENSOR DEVICE FOR MEASURING A FORCE EFFECTMarch 2023March 2026Allow3610NoNo
18018811Device For Inserting A Needle For Dispensing A Product In A SiteMarch 2023February 2026Allow3710NoNo
18180825STEERABLE INTRODUCER SHEATH ASSEMBLYMarch 2023September 2024Allow1920NoNo
18118066PATCH PUMP SYSTEMS AND APPARATUS FOR MANAGING DIABETES, AND METHODS THEREOFMarch 2023August 2024Allow1710NoNo
18116436ERGONOMIC STEERING HANDLEMarch 2023January 2025Allow2310NoNo
18173959SYSTEMS, APPARATUS, AND METHODS FOR FILTERING AIR FROM A FLUID LINEFebruary 2023June 2025Allow2811NoNo
18171339FLUID DELIVERY AND INFUSION DEVICES, AND METHODS OF USE THEREOFFebruary 2023August 2024Allow1810NoNo
18159694MECHANICALLY-DECOUPLED ACTUATION FOR ROBOTIC CATHETER SYSTEMJanuary 2023December 2025Allow3510NoNo
18101455Adjustable Stepped CannulaJanuary 2023May 2025Allow2820NoNo
18006213Valve Assembly for Drug Delivery DeviceJanuary 2023February 2026Allow3710NoNo
18157696DRUG DELIVERY DEVICEJanuary 2023January 2026Allow3630NoNo
18154211STEERABLE FLEXIBLE NEEDLE WITH EMBEDDED SHAPE SENSINGJanuary 2023January 2025Allow2410NoNo
18095348MEDICAMENT DELIVERY DEVICEJanuary 2023April 2024Allow1510NoNo
18015377MICRO DOSING DEVICE AND METHOD OF ASSEMBLY OF THE MICRO DOSING DEVICEJanuary 2023January 2026Allow3610NoNo
18094778MEDICAMENT DELIVERY DEVICEJanuary 2023July 2023Allow610NoNo
18093946SYSTEM AND METHOD FOR SYRINGE PLUNGER ENGAGEMENT WITH AN INJECTORJanuary 2023May 2024Allow1710NoNo
18014302CATHETERJanuary 2023September 2025Allow3200NoNo
18088491CONNECTOR COUPLING ASSEMBLYDecember 2022March 2026Allow3820NoNo
18083707PATIENT INTERFACEDecember 2022November 2023Allow1120YesNo
18082732Wearable Injector with Adhesive ModuleDecember 2022March 2025Abandon2720NoNo
18082074MEDICINE ADMINISTERING SYSTEM INCLUDING INJECTION PEN AND COMPANION DEVICEDecember 2022March 2025Allow2711NoNo
18008359CONTROLLED INJECTION BETWEEN TWO TISSUE LAYERS OF THE HUMAN EYEDecember 2022September 2025Allow3400NoNo
18075029USER-WEARABLE INFUSION PUMP HOLDERDecember 2022February 2026Allow3920NoNo
18070274DRUG DELIVERY SYSTEMNovember 2022February 2026Allow3810NoNo
17993309INTRAOCULAR DELIVERY DEVICES AND METHODS THEREFORNovember 2022October 2023Allow1120YesNo
17992418Protective Cap for Preventing Contamination of a Needle-Free ConnectorNovember 2022March 2026Allow4011NoNo
18058088CANNULAS FOR SYSTEMS AND METHODS FOR DELIVERING MICRODOSES OF MEDICATIONNovember 2022July 2023Allow820YesNo
18058003SYSTEMS AND METHODS FOR DELIVERING MICRODOSES OF MEDICATIONNovember 2022June 2023Allow610NoNo
17925804SAFETY DEVICE FOR A MEDICAMENT DELIVERY DEVICENovember 2022August 2025Allow3300NoNo
17987578In Vivo Gene Therapy Delivery Procedure and DeviceNovember 2022February 2025Allow2720NoNo
17983717CUSHION TO FRAME ASSEMBLY MECHANISMNovember 2022February 2023Allow310NoNo
17971080TOTAL JOINT REPLACEMENT INFECTION CONTROL DEVICES AND METHODSOctober 2022April 2025Allow3010NoNo
17959194RAPID FLUID DELIVERY SYSTEMOctober 2022December 2023Allow1430NoNo
17952445MEDICAL DEVICES HAVING RELEASABLE COUPLINGSeptember 2022August 2024Allow2320NoNo
17948088Injection Site Targeting DeviceSeptember 2022March 2025Allow3001NoNo
17931465BIORESORBABLE EMBOLIZATION MICROSPHERESSeptember 2022October 2024Abandon2510NoNo
17940233CATHETER AND CATHETER ASSEMBLYSeptember 2022July 2024Allow2210NoNo
17900262ROTATABLE INFUSION DEVICE AND METHODS THEREOFAugust 2022February 2024Allow1800NoNo
17897982APPARATUS, SYSTEMS AND METHODS FOR AN INFUSION PUMP ASSEMBLYAugust 2022April 2024Allow1910NoNo
17891990ANTIMICROBIAL DEVICE COMPRISING A CAP WITH RING AND INSERTAugust 2022June 2024Allow2210YesNo
17885730INJECTION DEVICE WITH TORSION SPRING AND ROTATABLE DISPLAYAugust 2022March 2026Abandon4340NoNo
17884402Introducer Components, Assemblies, and Methods ThereofAugust 2022September 2025Allow3710NoNo
17881170Ultrasonic Surgical Aspiration Needle Assembly with Molded HubAugust 2022June 2025Allow3400NoNo
17871334SYRINGE BARREL GRIP, BARREL ASSEMBLY, AND SYRINGEJuly 2022August 2025Allow3710NoNo
17812064SPACE-EFFICIENT FREE PISTON RESERVOIR FOR A WEARABLE DRUG DELIVERY DEVICEJuly 2022February 2026Allow4320NoNo
17855348MEDICAL SYSTEMS, DEVICES, AND RELATED METHODSJune 2022December 2025Allow4110NoNo
17846437Applicator For Cryoanesthesia And AnalgesiaJune 2022May 2024Allow2310NoNo
17787079IMPROVEMENTS IN NEEDLE-FREE DELIVERYJune 2022October 2025Allow4011NoNo
17842084CATHETER APPLICATOR AND METHOD OF USEJune 2022October 2025Allow4010NoNo

Appeals Overview

This analysis examines appeal outcomes and the strategic value of filing appeals for examiner BOUCHELLE, LAURA A.

Patent Trial and Appeal Board (PTAB) Decisions

Total PTAB Decisions
7
Examiner Affirmed
6
(85.7%)
Examiner Reversed
1
(14.3%)
Reversal Percentile
26.7%
Lower than average

What This Means

With a 14.3% reversal rate, the PTAB affirms the examiner's rejections in the vast majority of cases. This reversal rate is below the USPTO average, indicating that appeals face more challenges here than typical.

Strategic Value of Filing an Appeal

Total Appeal Filings
29
Allowed After Appeal Filing
3
(10.3%)
Not Allowed After Appeal Filing
26
(89.7%)
Filing Benefit Percentile
13.8%
Lower than average

Understanding Appeal Filing Strategy

Filing a Notice of Appeal can sometimes lead to allowance even before the appeal is fully briefed or decided by the PTAB. This occurs when the examiner or their supervisor reconsiders the rejection during the mandatory appeal conference (MPEP § 1207.01) after the appeal is filed.

In this dataset, 10.3% of applications that filed an appeal were subsequently allowed. This appeal filing benefit rate is in the bottom 25% across the USPTO, indicating that filing appeals is less effective here than in most other areas.

Strategic Recommendations

Appeals to PTAB face challenges. Ensure your case has strong merit before committing to full Board review.

Filing a Notice of Appeal shows limited benefit. Consider other strategies like interviews or amendments before appealing.

Examiner BOUCHELLE, LAURA A - Prosecution Strategy Guide

Executive Summary

Examiner BOUCHELLE, LAURA A works in Art Unit 3783 and has examined 499 patent applications in our dataset. With an allowance rate of 87.4%, this examiner has an above-average tendency to allow applications. Applications typically reach final disposition in approximately 31 months.

Allowance Patterns

Examiner BOUCHELLE, LAURA A's allowance rate of 87.4% places them in the 66% percentile among all USPTO examiners. This examiner has an above-average tendency to allow applications.

Office Action Patterns

On average, applications examined by BOUCHELLE, LAURA A receive 1.97 office actions before reaching final disposition. This places the examiner in the 49% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by BOUCHELLE, LAURA A is 31 months. This places the examiner in the 58% percentile for prosecution speed. Prosecution timelines are slightly faster than average with this examiner.

Interview Effectiveness

Conducting an examiner interview provides a +4.1% benefit to allowance rate for applications examined by BOUCHELLE, LAURA A. This interview benefit is in the 27% percentile among all examiners. Recommendation: Interviews provide a below-average benefit with this examiner.

Request for Continued Examination (RCE) Effectiveness

When applicants file an RCE with this examiner, 28.3% of applications are subsequently allowed. This success rate is in the 51% percentile among all examiners. Strategic Insight: RCEs show above-average effectiveness with this examiner. Consider whether your amendments or new arguments are strong enough to warrant an RCE versus filing a continuation.

After-Final Amendment Practice

This examiner enters after-final amendments leading to allowance in 49.5% of cases where such amendments are filed. This entry rate is in the 74% percentile among all examiners. Strategic Recommendation: This examiner shows above-average receptiveness to after-final amendments. If your amendments clearly overcome the rejections and do not raise new issues, consider filing after-final amendments before resorting to an RCE.

Pre-Appeal Conference Effectiveness

When applicants request a pre-appeal conference (PAC) with this examiner, 40.0% result in withdrawal of the rejection or reopening of prosecution. This success rate is in the 38% percentile among all examiners. Note: Pre-appeal conferences show below-average success with this examiner. Consider whether your arguments are strong enough to warrant a PAC request.

Appeal Withdrawal and Reconsideration

This examiner withdraws rejections or reopens prosecution in 68.2% of appeals filed. This is in the 54% percentile among all examiners. Of these withdrawals, 60.0% occur early in the appeal process (after Notice of Appeal but before Appeal Brief). Strategic Insight: This examiner shows above-average willingness to reconsider rejections during appeals. The mandatory appeal conference (MPEP § 1207.01) provides an opportunity for reconsideration.

Petition Practice

When applicants file petitions regarding this examiner's actions, 48.4% are granted (fully or in part). This grant rate is in the 44% percentile among all examiners. Strategic Note: Petitions show below-average success regarding this examiner's actions. Ensure you have a strong procedural basis before filing.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 2.8% of allowed cases (in the 78% percentile). Per MPEP § 1302.04, examiner's amendments are used to place applications in condition for allowance when only minor changes are needed. This examiner frequently uses this tool compared to other examiners, indicating a cooperative approach to getting applications allowed. Strategic Insight: If you are close to allowance but minor claim amendments are needed, this examiner may be willing to make an examiner's amendment rather than requiring another round of prosecution.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 4.1% of allowed cases (in the 78% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Examiner cooperation: This examiner frequently makes examiner's amendments to place applications in condition for allowance. If you are close to allowance, the examiner may help finalize the claims.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.